البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
lamotrigine, Quantity: 100 mg
Aspen Pharmacare Australia Pty Ltd
Tablet
Excipient Ingredients: calcium carbonate; hyprolose; aluminium magnesium silicate; sodium starch glycollate; povidone; saccharin sodium; magnesium stearate; Flavour
Oral
56 tablets, 60 tablets
(S4) Prescription Only Medicine
Lamictal is an anti-epileptic drug for the treatment of partial and generalised seizures in adults and children. There is extensive experience with Lamictal used initially as ?add-on? therapy. The use of Lamictal has also been found to be effective as monotherapy following withdrawal of concomitant anti-epileptic drugs. Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended (see CLINICAL TRIALS). Lamictal is indicated for the prevention of depressive episodes in patients with bipolar disorder.
Visual Identification: White to off-white tablet multifaceted super elliptical unscored plain on one side and '100' on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1995-04-26
LAMICTAL (lamotrigine) dispersible/chewable tablets – Consumer Medicine Information Page 1 of 5 LAMICTAL DISPERSIBLE/CHEWABLE TABLETS _lamotrigine _ CONSUMER MEDICINE INFORMATION (CMI) There are reports of severe, potentially life-threatening rashes associated with Lamictal treatment, particularly in children. Lamictal should be discontinued at the first sign of rash unless the rash is clearly not drug related. WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Lamictal tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Lamictal against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT LAMICTAL IS USED FOR Lamictal tablets contain lamotrigine as the active ingredient and belongs to a group of medicines called "anti-epileptic drugs". Anti-epileptic drugs such as Lamictal are used to treat several conditions, including epilepsy and bipolar disorder. It is used for the treatment of epilepsy in patients over 2 years of age. In general, it is initially used in addition to other medicines, for the treatment of epilepsy including partial or generalized seizures and Lennox- Gastaut syndrome. It is thought that this medicine works by changing the levels of some chemicals associated with seizures. Lamictal is also used to help prevent depression in adults over 18 years of age with bipolar disorder. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY LAMICTAL HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is only available with a doctor’s prescription. It is not addictive. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE LAMICTAL IF YOU HAVE EVER HAD AN ALLERGIC REACTION TO: lamotrigine any of the ingredients liste اقرأ الوثيقة كاملة
LAMICTAL (lamotrigine) – Product Information Page 1 of 35 AUSTRALIAN PRODUCT INFORMATION LAMICTAL (LAMOTRIGINE) DISPERSIBLE/CHEWABLE TABLETS LAMICTAL (LAMOTRIGINE) TABLETS 1 NAME OF THE MEDICINE Lamotrigine. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION LAMICTAL dispersible/chewable tablets and LAMICTAL tablets (uncoated) contain lamotrigine. List of excipients with known effect: saccharin (for LAMICTAL dispersible/chewable tablets) and sugars as lactose (for LAMICTAL uncoated tablets) For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM LAMICTAL DISPERSIBLE/CHEWABLE TABLETS* 2 MG BOTTLES [AUST 77098]: White to off-white round tablets with an odour of blackcurrant. They are marked "LTG2" on one side and engraved with two overlapping super-ellipses on the other. 5 MG BLISTER PACKS [AUST R 51547]: White to off-white, elongated, biconvex, unscored tablets with an odour of blackcurrant. They are marked "GSCL2” on one side and ‘5’ on the other. The tablets may be slightly mottled. 5 MG BOTTLES [AUST R 51718]: White to off-white caplet shaped biconvex tablet embossed with ‘5’ on one side and plain on the other side. 25 MG BLISTER PACKS [AUST R 51548]: White to off-white tablet multifaceted super elliptical unscored plain on one side and ‘25’ on the other side. 25 MG BOTTLES [AUST R 51739]: White to off-white, multi-faceted, superelliptical, unscored tablets with an odour of blackcurrant. They are marked "GSCL5" on one side and “25” on the other. The tablets may be slightly mottled. 50 MG BLISTER PACKS [AUST R 57190]: White to off-white tablet multifaceted super elliptical unscored plain on one side and ‘50’ on the other side. Severe, potentially life-threatening rashes have been reported in association with the use of lamotrigine, particularly in children. Accordingly, lamotrigine should be discontinued at the first sign of rash unless the rash is clearly not drug related (see Section 4.2, DOSE AND METHOD OF ADMINISTRATION.) LAMICTAL (lamotrigine) – Product I اقرأ الوثيقة كاملة